IRCT20160131026298N4
Recruiting
Phase 2
Pilot clinical trial to evaluate the effectiveness of Herbal Cyclotide complex syrup as a prevention of disease complications in people exposed to COVID-19 virus
Bagheiat-allah University of Medical Sciences0 sites60 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Bagheiat-allah University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •People over the age of 18 who have had close contact with a person with COVID\-19 in the last 4 days and signed an informed consent form (close contact is defined as those who live at home with an infected person or depending on their employment situation in Less than two meters away from the infected person.) And have no previous or current history of COVID\-19\.
- •Age between 18 and 70 years
- •No previous diagnosis of COVID\-19 (if possible, test negative for IgG and IgM antibodies.)
- •Absence of symptoms such as fever, body aches, olfactory and taste disturbances, cough, shortness of breath, diarrhea in the last 1 month
Exclusion Criteria
- •Current incidence of COVID\-19 is confirmed by PCR and clinical signs.
- •History of autoimmune disease
- •History of rheumatic disease
- •Pregnancy and lactation
- •Age under 18 years
- •People sensitive to any component of the product
- •People who can not follow up.
- •Any clinical reason that may prevent you from entering the study.
- •Do not take two doses of the drug
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 2
Clinical Study to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis)Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecifiedCTRI/2023/09/057492I
Not Yet Recruiting
N/A
Clinical trial to evaluate efficacy of chitramutti madakku thailam peechu therapy in the management of thandagavathsmHealth Condition 1: M959- Acquired deformity of musculoskeletal system, unspecifiedCTRI/2023/10/058490nil
Completed
Phase 1
A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy.Chemotherapy induced peripheral neuropathyCancer - Other cancer typesACTRN12611000078954niversity of Queensland - Centre for Integrative Clinical and Molecular Medicine135
Not Yet Recruiting
N/A
A trial to explore the effectiveness of siddha treatment for pakkavatham ( Hemiplegic stroke)CTRI/2023/09/057216il
Completed
N/A
A pilot clinical trial to evaluate the efficacy and safety of R:GEN(Selective retina therapy) which induce to reduce drusen in patients with intermediate dry Age-related Macular DegeneratioDiseases of the eye and adnexaKCT0003227The Catholic University of Korea, Yeouido St. Mary's Hospital20